⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

VTRS

Viatris Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

16.50USD

-0.1100 (-0.66%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 16.50
P/E—
Dvd Ind Yld2.9%
P/B1.33
P/S1.3
Curr EV/T12M EBITDA11.5
Mkt Cap (USD)19.0B
Curr EV (USD)31.2B
2)

Per Share Data

EPS T12M-0.36
DPS0.48
Bk Val Per Sh12.59
Rev/Sh12.63
Cash/Sh1.32
Curr Shares Out1,148.6M
FCF/Sh1.68
3)

Cash Flow Analysis

P/CF8.1
Curr P/FCF9.7
CF/NI-3.5
Dvd P/O960.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales15.9%
Eff Interest Rate3.5%
4)

Growth Potential

Dil EPS 1Y Gr-466.0%
Cap 1Y Gr-10.9%
BPS 1Y Gr-2.0%
R&D To Sales6.6%
Retention Rate-860.0%
Rev 1Y Gr-3.0%
FCF 1Y Gr-2.0%
Assets 1Y Gr-10.4%
5)

Profitability

EBITDA2.7B
EBIT-0.1B
Operating Margin-0.6%
Pretax Margin-4.5%
Net Margin-4.6%
ROA-1.8%
ROE-4.5%
ROC-0.2%
Asset Turnover0.40
6)

Structure

Current Ratio1.58
Quick Ratio0.82
Debt/Assets38.1%
Debt/Com Eq93.6%
Net Debt/EBITDA4.59
Tot Debt/Capital48.3%
Gross Margin34.9%
EBIT/Int Exp-0.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.